Peter Madsen to switch prisons following attack

Murderer’s new home will mostly house hardened criminals undergoing treatment

Peter Madsen, the submariner who murdered journalist Kim Wall in August 2017, will be allowed to leave his current home, Storstrøm Prison, once a room at Herstedvester Prison becomes available, his lawyer Betina Hald Engmark has told BT.

Madsen was attacked last week on Wednesday at Storstrøm, a penal institution for mostly ordinary criminals, by an 18-year-old man. Madsen was not seriously injured.

Most undergoing treatment
At Herstedvester, in contrast, most of the 150 inmates are undergoing some form of treatment. Most are serving long sentences for serious crimes such as murder, serious violence or rape.

Madsen’s appeal against the length of his sentence is due to start on September 5 at the Østre Landsret eastern high court.





  • How internationals can benefit from joining trade unions

    How internationals can benefit from joining trade unions

    Being part of a trade union is a long-established norm for Danes. But many internationals do not join unions – instead enduring workers’ rights violations. Find out how joining a union could benefit you, and how to go about it.

  • Internationals in Denmark rarely join a trade union

    Internationals in Denmark rarely join a trade union

    Internationals are overrepresented in the lowest-paid fields of agriculture, transport, cleaning, hotels and restaurants, and construction – industries that classically lack collective agreements. A new analysis from the Workers’ Union’s Business Council suggests that internationals rarely join trade unions – but if they did, it would generate better industry standards.

  • Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    The numbers are especially striking amongst the 3,477 business and economics students polled, of whom 31 percent elected Novo Nordisk as their favorite, compared with 20 percent last year.